UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012469
Receipt number R000014594
Scientific Title Comparison of Adalimumab and Steroid in Intestinal Behcet's disease
Date of disclosure of the study information 2013/12/02
Last modified on 2024/03/31 23:50:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of Adalimumab and Steroid
in Intestinal Behcet's disease

Acronym

Castle Study

Scientific Title

Comparison of Adalimumab and Steroid
in Intestinal Behcet's disease

Scientific Title:Acronym

Castle Study

Region

Japan


Condition

Condition

Intestinal Behcet's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison with adalimumab and steroid for the efficacy of remission induction in patients with intestinal Behcet's disease

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Endoscopic efficacy at 12 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Subcutaneous injection of adalumumab with 160mg at 0 week, 80mg at 2 weeks and 40mg every other week after at 4 weeks continuously.

Interventions/Control_2

Oral administration of prednisolone with 0.6mg/kg/day during from 1 to 2 weeks, and tapering off until 12 weeks with decreasing dosage 5mg/kg/week approximately

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with intestinal Behcet's disease who were refractory to conventional treatment and contained with typical punched-out ulce in the cecum.

Key exclusion criteria

1) The patients with simple ulcer disease complicated without general Behcet's symptoms
2) Contraindication of adalimumab administration
a: Severe infectious disease
b: Active tuberculosis
c: Past history for hypersensitivity of adalimumab contents
d: Present or past history for demyelinating disorder
e: Congestive heart failure
3) Contraindication for steroid administration
a: Past history for hypersensitivity of prednisolone contents
4) Pregnant or breast feeding woman
5) Below the age of 15 years old
6) The patients who are unable to provide informed consent
7) The patients who are begun to administrate with more than 10mg/kg steroid within 2 weeks
8) The patients who are administrated with steroid more than 2 weeks
9) The patients who had been administrated with infliximab or adalimumab. However, the patients who were intolerant for infliximab within 2nd infusion (0 week or 2 weeks) can be enrolled.
10) The patients who are added or increased dosage of administration with as follows, 5-aminosalicylates or nutrition therapy within 2 weeks, colchicine or tacrolimus or ciclosporin or methotrexate within 4 weeks, azathioprine or 6-mercaptopurine within 8 weeks
11) Malignancy patient
12) The patients who are contained with untypical lesion for intestinal Behcet's disease
13) The patients who are indicated as insufficient by the physician

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kenji
Middle name
Last name Watanabe

Organization

Osaka City University

Division name

Department of Gastroenterology

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku, Osaka

TEL

06-6645-3811

Email

kenjiw1779@gmail.com


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Watanabe

Organization

Osaka City University

Division name

Department of Gastroenterology

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku, Osaka

TEL

06-6645-3811

Homepage URL


Email

kenjiw1779@gmail.com


Sponsor or person

Institute

Castle Study Group

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka City University Hospital Certified Review Board

Address

1-2-7-601, Asahi-machi, Abeno-ku, Osaka

Tel

06-6645-3435

Email

ethics@med.osaka-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 10 Month 03 Day

Date of IRB

2013 Year 10 Month 03 Day

Anticipated trial start date

2013 Year 12 Month 02 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 02 Day

Last modified on

2024 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014594


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name